4
Changes in Ownership
Relay Therapeutics, Inc. Filed Acc 0001209191-23-026277
Chief Financial Officer sold 863 shares at $11.16 ($9,631)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Catinazzo Thomas Chief Financial Officer | 2023-04-28 | Sale | −863 | $11.16 | $9,631 | 149,272 | D |
| Open-market sales · 863 sh · avg $11.16 · $9,631 | |||||||
Loading xslF345X04/doc4.xml…